We are live on ! Find out more
FI

Fosun International Portfolio holdings

AUM $399M
1-Year Est. Return 16.11%
This Fund
S&P 500
This Quarter Est. Return
+13.75%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$810M
AUM Growth
+$9.37M
Cap. Flow
-$84.4M
Cap. Flow %
-10.42%
Top 10 Hldgs %
74.22%
Holding
40
New
11
Increased
5
Reduced
6
Closed
5

Top Sells

Rank Stock Value
1
SINA
Sina Corp
SINA
+$66.1M
2
AKRX
Akorn Inc
AKRX
+$49.3M
3
JOYY
JOYY Inc
JOYY
+$34.5M
4
MMYT icon
MakeMyTrip
MMYT
+$8.48M
5
ONC
BeOne Medicines Ltd
ONC
+$6.35M

Sector Composition

Rank Sector Weight
1 Communication Services 21.5%
2 Healthcare 13.28%
3 Financials 8.3%
4 Consumer Staples 4.67%
5 Consumer Discretionary 2.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SINA
1
DELISTED
Sina Corp
SINA
$108M 13.37%
1,273,918
-784,796
-38% -$66.1M
SFUN
2
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$93.1M 11.5%
502,149
JOYY
3
JOYY Inc
JOYY
$3.61B
$90.6M 11.19%
1,560,969
-651,076
-29% -$34.5M
SOHU
4
Sohu.com
SOHU
$346M
$83.6M 10.32%
1,854,319
NATR icon
5
Nature's Sunshine
NATR
$369M
$37.8M 4.67%
2,854,607
KANG
6
DELISTED
iKang Healthcare Group, Inc.
KANG
$31.3M 3.86%
2,547,939
BHC icon
7
Bausch Health
BHC
$1.75B
$30.8M 3.8%
1,780,069
+446,146
+33% +$5.35M
AIFU
8
AIFU Inc
AIFU
$196M
$28.9M 3.57%
+8,453
New +$29.4M
DBRG icon
9
DigitalBridge
DBRG
$2.92B
$19.7M 2.43%
348,982
-109,609
-24% -$5.95M
COWN
10
DELISTED
Cowen Inc. Class A Common Stock
COWN
$18.6M 2.3%
1,145,187
+740,450
+183% +$11.1M
VER
11
DELISTED
VEREIT, Inc.
VER
$15.6M 1.93%
+383,846
New +$15.9M
DOVA
12
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
$14.5M 1.79%
+650,000
New +$13.7M
BYSI icon
13
BeyondSpring
BYSI
$51M
$10.3M 1.27%
240,000
BBWI icon
14
Bath & Body Works
BBWI
$4.13B
$9.39M 1.16%
+215,516
New +$8.83M
MMYT icon
15
MakeMyTrip
MMYT
$5.05B
$9.01M 1.11%
268,681
-244,200
-48% -$8.48M
GILD icon
16
Gilead Sciences
GILD
$165B
$8.76M 1.08%
123,759
+37,300
+43% +$2.48M
IPXL
17
DELISTED
Impax Laboratories, Inc.
IPXL
$4.83M 0.6%
300,000
OXFD
18
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$4M 0.49%
237,783
-171,263
-42% -$2.56M
NCLH icon
19
Norwegian Cruise Line
NCLH
$8.95B
$3.38M 0.42%
62,214
TGA
20
DELISTED
Transglobe Energy Corp
TGA
$3.24M 0.4%
2,422,923
MBAI
21
Check-Cap
MBAI
$7.34M
$2.95M 0.36%
6,378
ONC
22
BeOne Medicines Ltd
ONC
$32.2B
$2.4M 0.3%
53,451
-161,228
-75% -$6.35M
JNCE
23
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.46M 0.18%
+92,610
New +$1.98M
GSK icon
24
GSK
GSK
$100B
$1.03M 0.13%
+19,040
New +$1.02M
CHEKW
25
DELISTED
Check-Cap Ltd. Series A Warrant
CHEKW
$217K 0.03%
333,333

Similar funds

Fosun International's Q2 2017 Portfolio in Review

As of Q2 2017, Fosun International held 40 positions worth $810M, up 1.2% from $800M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Fosun International withdrew a net $84.4M in Q2 2017, closing 5 positions and reducing 6 holdings. Its most notable exit was Akorn Inc, an estimated $49.3M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Fosun International opened a new position in AIFU Inc worth $28.9M.

  • Fosun International's largest Q2 2017 buy was AIFU Inc: 8,453 shares worth $28.9M.
  • Fosun International added most to Cowen Inc. Class A Common Stock in Q2 2017, an estimated $11.1M increase.
  • Fosun International's biggest Q2 2017 reduction was Sina Corp, cutting an estimated $66.1M.
  • Fosun International fully exited Akorn Inc in Q2 2017, selling an estimated $49.3M.
  • Fosun International's ten largest holdings make up 74% of its $810M portfolio in Q2 2017.
  • Fosun International opened 11 new positions and closed 5 in Q2 2017.
  • Fosun International's portfolio value rose 1.2% quarter-over-quarter to $810M.

Based on Fosun International's 13F filing for Q2 2017, filed 11 Aug 2017.